Penumbra Inc. (PEN)
PEN trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$320.01
-0.30% on the day
Market cap
$12.6B
Large cap
Revenue · 2025
$1.4B
+17.5% on 2024
Net income · 2025
$177.7M
12.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PEN on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2015 |
| SEC CIK | 0001321732 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.4B |
| Net income | $177.7M |
| Operating income | $189.2M |
| Net margin | 12.7% |
| Operating margin | 13.5% |
| Revenue growth | +17.5% |
| Cash | $186.9M |
| Total assets | $1.8B |
| P/E (computed) | 70.9× |
| P/S (computed) | 9.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2023-02-23 |
| Latest annual report | 10-K | 2026-02-25 |
| Latest quarterly / interim | 10-Q | 2026-07-30 |
| Latest current report | 8-K | 2026-07-30 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 952 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +1.2% |
| 1 month | +0.5% |
| 3 months | +0.1% |
| Year to date | +2.9% |
| 1 year | +26.4% |
| From 52-week high | -11.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BAX | Baxter International Inc. | $24.89 | +0.44% | $12.9B |
| SOLV | Solventum Corporation | $86.30 | +1.16% | $14.7B |
| GMED | Globus Medical Inc. | $76.32 | +0.10% | $10.2B |
| GKOS | Glaukos Corporation | $165.50 | -1.50% | $9.8B |
| PODD | Insulet Corporation | $138.13 | -1.20% | $9.6B |
| WST | West Pharmaceutical Services Inc. | $371.82 | +1.15% | $26.2B |
| HAE | Haemonetics Corporation | $121.72 | -0.28% | $5.5B |
| TFX | Teleflex Incorporated | $124.44 | -1.00% | $5.3B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier